GlassScriptPhysician profile
Ryan G Smith
NPI 1164809851
$147,493.67
in general payments reported to CMS, 2019-2025
37 companies · $69K in 2025
The $69K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $173 · 2021: $4,257 · 2022: $14K · 2023: $9,328 · 2024: $50K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Consulting Fee: $44K · Food and Beverage: $17K · Travel and Lodging: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,175 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,145.50 |
| Consulting Fee | $44,375.50 |
| Food and Beverage | $17,284.00 |
| Travel and Lodging | $11,405.98 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,175.00 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $42,525.69 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $41,346.26 | 2019-2025 | Lipiflow System Activator (Disposable), Tecnis Simplicity, Veritas Vision System |
| Bausch & Lomb Americas INC. | $21,022.67 | 2022-2025 | Stellaris Elite, Envista Mx60 Iol, Ic-8 Apthera Iol |
| Glaukos Corporation | $20,795.68 | 2020-2025 | Idose, Ce-Marked Kxla System, Travoprost Intraocular Implant - Idose |
| Rxsight INC | $3,585.22 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Dompe US, INC. | $3,064.32 | 2021-2025 | Oxervate |
| Alcon Research LLC | $3,000.00 | 2024 | |
| Mallinckrodt Hospital Products INC. | $1,969.37 | 2021-2025 | Acthar |
| Abbvie INC. | $1,642.91 | 2022-2025 | Alphagan P, Vuity, Lumigan |
| Sight Sciences, INC. | $1,589.27 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument, Tearcare System |
| Alcon Vision LLC | $1,475.07 | 2021-2025 | Clareon, Hydrus Microstent, Unity |
| Lensar, INC. | $1,056.41 | 2024-2025 | Lensar Laser System |
| Tearlab Corp | $888.72 | 2024 | Scoutpro Osmolarity System |
| Beaver-Visitec International, INC. | $613.07 | 2021-2025 | |
| Harrow Eye, LLC | $406.75 | 2024-2025 | Iheezo, Flarex, Verkazia |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.